Table 3 Baseline and peak hepatobiliary data and inflammation markers during hospitalization in the cardiology department
Variables | Group 1, n = 5 | Group 2, n = 11 |
|---|---|---|
On admission | ||
 White blood cell count, ×103/mL | 9.4 (3.3–20.7) | 9.3 (5.8–14.8) |
 Aspartate transaminase, IU/L | 198 (25–293) | 23 (17–81) |
 Alanine transaminase, IU/L | 51 (24–182) | 25 (14–46) |
 γ-Glutamyl transpeptidase, IU/L | 87 (23–301) | 78 (29–208) |
 Alkaline phosphatase, IU/L | 205 (189–333) | 273 (170–418) |
 Total bilirubin, mg/dL | 0.7 (0.6–1.0) | 0.8 (0.6–1.1) |
 C-reactive protein, mg/dL | 0.10 (0.04–3.71) | 3.09 (0.54–5.94) |
Peak values during hospitalization in Cardiology Department | ||
 White blood cell count, ×103/mL | 14.2 (3.5–23.9) | 9.3 (7.3–15.5) |
 Aspartate transaminase, IU/L | 283 (34–314) | 150 (34–300) |
 Alanine transaminase, IU/L | 54 (38–182) | 67 (38–263) |
 γ-Glutamyl transpeptidase, IU/L | 202 (50–592) | 218 (33–461) |
 Alkaline phosphatase, IU/L | 206 (193–302) | 536 (261–1099) |
 Total bilirubin, mg/dL | 1.3 (0.7–2.5) | 1.7 (0.7–2.7) |
 C-reactive protein, mg/dL | 8.85 (1.32–13.80) | 6.94 (4.89–13.03) |